WallStreetZenWallStreetZen

NASDAQ: PHIO
Phio Pharmaceuticals Corp Stock Ownership - Who owns Phio Pharmaceuticals?

Insider buying vs selling

Have Phio Pharmaceuticals Corp insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Robert J. BittermanPresident CEO2024-06-071,000$0.74
$740.00Buy
Robert J. BittermanPresident CEO2024-06-061,000$0.75
$750.00Buy
Caitlin KontulisSecretary VP Finance Admin2024-03-01335$0.96
$320.93Sell
Robert J. BittermanPresident CEO2024-02-262,500$0.91
$2.28kBuy
Robert J. BittermanPresident CEO2024-02-201,804$0.76
$1.37kSell
Caitlin KontulisSecretary VP Finance Admin2024-02-17523$0.66
$345.18Sell
Caitlin KontulisSecretary VP Finance Admin2024-02-15658$0.65
$427.70Sell

1 of 1

PHIO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PHIO insiders and whales buy or sell their stock.

PHIO Shareholders

What type of owners hold Phio Pharmaceuticals Corp stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Opko Health Inc7,812.22%67,241,380$219.21MInsider
Sellas Life Sciences Group Inc3,763.48%32,393,095$105.60MInsider
Advanced Rna Technologies LLC141.94%1,221,723$3.98MInsider
Alexey Eliseev110.41%950,312$3.10MInsider
John A. Barrett25.91%222,991$726.95kInsider
Gerrit Dispersyn24.67%212,327$692.19kInsider
Cetera Investment Advisers4.11%35,416$115.46kInstitution
Geode Capital Management LLC3.27%28,136$91.72kInstitution
Vanguard Group Inc2.83%24,380$79.48kInstitution
Bridgeway Capital Management LLC2.73%23,486$76.56kInstitution

1 of 3

PHIO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PHIO0.16%99.84%Net Buying
PTIX3.58%1.03%
MTNB56.56%43.44%
QNRX1.13%98.87%Net BuyingNet Buying
ATNF0.08%99.92%Net Buying

Phio Pharmaceuticals Stock Ownership FAQ

Who owns Phio Pharmaceuticals?

Phio Pharmaceuticals (NASDAQ: PHIO) is owned by 19.53% institutional shareholders, 11,892.99% Phio Pharmaceuticals insiders, and 0.00% retail investors. Opko Health Inc is the largest individual Phio Pharmaceuticals shareholder, owning 67.24M shares representing 7,812.22% of the company. Opko Health Inc's Phio Pharmaceuticals shares are currently valued at $218.53M.

If you're new to stock investing, here's how to buy Phio Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.